International arbitration counsel.
International arbitration resolves cross-border disputes outside national courts under chosen institutional rules. The firm acts as counsel or co-counsel in commercial and investment-treaty arbitrations under the Swiss Rules, ICC, DIS and other major rules, and accepts appointment as sole, co- or emergency arbitrator, with subject-matter depth in life-sciences disputes.
Who this is for
- Parties to life-sciences-related disputes: distribution, licensing, supply and post-M&A disputes.
- Companies and counsel needing co-counsel with technical and linguistic range for a cross-border arbitration.
- Institutions and parties seeking an arbitrator for commercial or investment-treaty matters in the life-sciences field.
What's included
- Counsel and co-counsel: representation of a party in commercial and investment-treaty arbitrations under the Swiss Rules, ICC, DIS and other major institutional and ad hoc rules.
- Arbitrator appointments: appointment as sole arbitrator, co-arbitrator or emergency arbitrator (MCIArb), kept strictly separate from any counsel role in the same matter.
- Investment-treaty arbitration: a confirmed capability, drawing on dedicated study in investment-treaty arbitration, for treaty claims involving regulated health products and investments.
- Life-sciences subject-matter depth: disputes over distribution, licensing and supply arrangements for medicinal products and medical devices, where regulatory context shapes the merits.
- Post-M&A disputes: earn-out, warranty and indemnity disputes following a life-sciences transaction; this is a dispute descriptor only, as the firm does not act on corporate or M&A transactions.
- Seat and procedural framework: advice on rules, seat and applicable law; for arbitrations seated in Switzerland, Chapter 12 of the IPRG applies as the governing law of the arbitration, with specific provisions confirmed at engagement.
How it works
- Conflicts and intake. The firm runs a conflicts check and confirms the role sought (counsel, co-counsel or arbitrator appointment) before any substantive work begins.
- Case and forum assessment. The firm assesses the dispute, the arbitration agreement, the applicable rules, the seat and the governing law.
- Strategy. The firm sets the procedural and merits strategy, including tribunal constitution and any interim or emergency measures.
- Conduct of the proceeding. The firm runs the written and oral phases as counsel, or discharges the tribunal's mandate impartially where appointed as arbitrator.
- Award and enforcement. The firm advises on the award and, for a party, on recognition and enforcement across the relevant jurisdictions.
Indicative pricing
Phased fixed fees with caps
CHF 750 to 1,100 / hour
Phased fixed fees with a per-phase cap; an early-case assessment at CHF 12,000 to 18,000; lead counsel to CHF 1,100 / hour and hearing days at CHF 9,500 to 11,000 / day; institutional and tribunal fees are passed through transparently.
Indicative starting prices, net and exclusive of Swiss MWST (VAT) where applicable; final fee per written engagement letter.
Frequently asked questions
- Does the firm act as counsel, as arbitrator, or both?
- Both, in separate matters. The firm acts as counsel or co-counsel for a party to a dispute, and separately accepts appointment as sole arbitrator, co-arbitrator or emergency arbitrator where the dispute calls for an arbitrator with technical and linguistic range. The two roles are never combined in the same proceeding, and conflicts are checked before any engagement.
- What rules and seats does the firm work under?
- The firm acts in arbitrations under the Swiss Rules, the ICC Rules, the DIS Rules and other major institutional and ad hoc frameworks. For arbitrations seated in Switzerland, Chapter 12 of the IPRG governs international arbitration as the lex arbitri. The governing rules, seat and applicable law are confirmed for each matter at engagement.
- Does the firm handle investment-treaty arbitration?
- Yes. Investment-treaty arbitration is a confirmed capability, alongside commercial arbitration. Engagements draw on dedicated study in investment-treaty arbitration and combine treaty-claim experience with the firm's life-sciences subject-matter depth, which is relevant where the underlying investment concerns regulated health products.
- What kinds of life-sciences disputes does the firm arbitrate?
- Disputes arising from distribution, licensing and supply arrangements for regulated health products, and post-M&A disputes such as earn-out, warranty and indemnity claims following a life-sciences transaction. Post-M&A disputes are a dispute descriptor only; the firm does not act on the underlying corporate or M&A transactions.